Middle EAST Monoclonal Antibodies Market Intelligence Study: Current Scenario and Future Potential
The Middle EAST Monoclonal Antibodies Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 12.8 billion by 2034, registering a CAGR of 9.2%. This growth trajectory is underpinned by several factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and heightened investments in healthcare infrastructure. The demand for monoclonal...
0 Bình luận
0 Chia sẻ
250 Lượt xem
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)